0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-05-01 Sage Accounts Production Advanced 2023 - FRS102_2023 201 201 201 xbrli:pure xbrli:shares iso4217:GBP 06357751 2023-05-01 2024-04-30 06357751 2024-04-30 06357751 2023-04-30 06357751 2022-05-01 2023-04-30 06357751 2023-04-30 06357751 2022-04-30 06357751 bus:Director2 2023-05-01 2024-04-30 06357751 core:WithinOneYear 2024-04-30 06357751 core:WithinOneYear 2023-04-30 06357751 core:ShareCapital 2024-04-30 06357751 core:ShareCapital 2023-04-30 06357751 core:RetainedEarningsAccumulatedLosses 2024-04-30 06357751 core:RetainedEarningsAccumulatedLosses 2023-04-30 06357751 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 06357751 core:Non-currentFinancialInstruments 2024-04-30 06357751 core:Non-currentFinancialInstruments 2023-04-30 06357751 bus:SmallEntities 2023-05-01 2024-04-30 06357751 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 06357751 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 06357751 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 06357751 bus:FullAccounts 2023-05-01 2024-04-30
COMPANY REGISTRATION NUMBER: 06357751
Beaucare Group Limited
Filleted Unaudited Financial Statements
30 April 2024
Beaucare Group Limited
Statement of Financial Position
30 April 2024
2024
2023
Note
£
£
£
Fixed assets
Investments
4
201
201
Creditors: amounts falling due within one year
5
151
151
----
----
Net current liabilities
151
151
----
----
Total assets less current liabilities
50
50
----
----
Capital and reserves
Called up share capital
1
1
Profit and loss account
49
49
----
----
Shareholder funds
50
50
----
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 24 January 2025 , and are signed on behalf of the board by:
J Storr
Director
Company registration number: 06357751
Beaucare Group Limited
Notes to the Financial Statements
Year ended 30 April 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Beaucare Medical Hornbeam Square West, Hornbeam Park, Harrogate, HG2 8PA.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
4. Investments
Shares in group undertakings
£
Cost
At 1 May 2023 and 30 April 2024
201
----
Impairment
At 1 May 2023 and 30 April 2024
----
Carrying amount
At 30 April 2024
201
----
At 30 April 2023
201
----
5. Creditors: amounts falling due within one year
2024
2023
£
£
Other creditors
151
151
----
----
6. Related party transactions
No transactions with related parties were undertaken such as are required to be disclosed under FRS102.